Previous 10 | Next 10 |
Image source: The Motley Fool. Progyny, Inc. (NASDAQ: PGNY) Q1 2020 Earnings Call May 12, 2020 , 4:45 p.m. ET Operator Continue reading
Progyny, Inc. (PGNY) Q1 2020 Earnings Conference Call May 12, 2020 4:45 P.M. ET Company Participants James Hart - Vice President, Investor Relations David Schlanger - Chief Executive Officer Pete Anevski - President, Chief Financial Officer and Chief Operating Officer Conferen...
Gainers: SIF +81.6% . EDAP +27.0% . AVNW +26.5% . PGNY +20.7% . XP +8.9% . More news on: SIFCO Industries, Inc., EDAP TMS S.A., Aviat Networks, Inc., Stocks on the move, , Read more ...
Progyny (NASDAQ: PGNY ): Q1 Non-GAAP EPS of $0.04 beats by $0.02 ; GAAP EPS of $0.04 beats by $0.06 . Revenue of $81.02M (+71.7% Y/Y) beats by $9.21M . Press Release More news on: Progyny, Inc., Earnings news and commentary, Healthcare stocks news,
Company Well-Positioned to Successfully Manage COVID-Related Impacts Reports 72% Increase in First Quarter Revenue to $81.0 Million Reports $12.1 Million in Quarterly Operating Cash Flow, Adding to its Already Strong Balance Sheet NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. ...
NEW YORK, May 05, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Pete Anev...
NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, announced today the company will virtually ring the Nasdaq Stock Market Opening Bell on Apr...
One biotech IPO is scheduled for the week ahead, and pipeline activity indicates that a few more may be on the way. ORIC Pharmaceuticals (ORIC), a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, plans to raise $75 million at a $424 million market cap. The...
NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2020 after the c...
There were no IPOs this past week, but initial filings from a biotech and a Chinese issuer are keeping the IPO market moving. After another strong week, the IPO Index is now up about 35% from its March lows. As we pointed out in our 1Q20 IPO Review, the first IPOs to emerge from the shutdown...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended June 30, 2024 after the close of the market on Tuesday, August 6, 20...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded...